News

Antiretroviral Switch Linked to Drop in Bone Density

Publish date: March 28, 2012

 

FROM THE CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS

Dr. Cotter disclosed no relevant conflicts of interest. The PREPARE trial was supported by an unrestricted scientific grant from Gilead Sciences.

Pages

Recommended Reading

Azithromycin Cuts Carriage of Shiga Toxin-Producing E. coli
MDedge Internal Medicine
One-Third of HIV-Positive Adults Receive Regular Medical Care
MDedge Internal Medicine
Investigational Herpes Drug May Offer Alternative to Valacyclovir
MDedge Internal Medicine
Metformin May Benefit Heart in HIV Patients
MDedge Internal Medicine
HIV Exacerbates Heart Risk from Hypertension
MDedge Internal Medicine
Lyme Disease Presents Differently in Men and Women
MDedge Internal Medicine
Gastroenteritis Deaths Soar, Largely Due to C. difficile, Norovirus
MDedge Internal Medicine
Risk Factors for C. difficile Recurrence Identified
MDedge Internal Medicine
When Diagnosed, Women Help Treat Partners for Chlamydia
MDedge Internal Medicine
Azithromycin, Doxycycline Quell Nongonococcal Urethritis in Men
MDedge Internal Medicine